Anti-HIV Drug Current Events | Anti-HIV Drug News
|
| Page
1 of
94 |
1879 Results |
|
|
|
Sort By:
Page Views | Date |
Transmission of drug-resistant HIV-1
Drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment. view more (2009-03-30)
Asthma risk increases in children treated for HIV
Children whose immune systems rebound after treatment with potent anti-viral drugs for HIV infection face an increased risk of developing asthma, said a federally funded consortium of researchers led by those from Baylor College of Medicine in a report that appears online in the Journal of Allergy and Clinical Immunology. view more (2008-07-02)
Exciting Development in Anti-Retroviral Drug Discovery Made at Oxford
Researchers in Oxford University's Sir William Dunn School of Pathology have developed a novel HTS for identifying antiretroviral (HIV) agents/drugs that inhibit HIV infectivity. Current anti-viral drugs prolong the quality of life for many HIV-1+ individuals, but they do not stop the virus from infecting new cells. Since these drugs mostly... view more... (2003-06-05)
ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs
Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells. view more (2008-08-27)
NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
Most vaccines that protect against viruses generate infection-fighting proteins called antibodies that either block infection or help eliminate the virus before it can cause disease. view more (2009-06-15)
Transplants In HIV Patients Should Proceed But Drug Interactions Can Be Concern, Concludes Research At International Congress Of The Transplantation Society
While historically surgeons have been reluctant to transplant patients with the human immunodeficiency virus (HIV), in recent years, some centers have begun to accept patients with well-controlled HIV as candidates for liver or kidney transplantation. Based on results of three studies from the United States and one from France, which collectively... view more... (2002-08-20)
Waking up dormant HIV
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells. view more (2009-03-17)
Herpes drug inhibits HIV in patients infected with both viruses
Researchers at the U.S. National Institutes of Health (NIH), McGill University and other institutions have discovered how a simple antiviral drug developed decades ago suppresses HIV in patients who are also infected with herpes. view more (2008-09-16)
Tools for more accurate dosage of drugs against HIV/AIDS and malaria
A doctoral thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden, shows that it is possible to describe and quantify the relationships between dose, concentration and effectiveness of several drugs against HIV/AIDS and malaria. The method may allow improved treatment and fewer undesired effects for patients with these... view more... (2009-03-06)
HIV drugs, Abacavir and Didanosine, increase the risk of heart attack
A study to assess the adverse effects of anti-retroviral drugs shows that two of the widely used HIV drugs are associated with an increased risk of heart attack/the formation of blood clots in the heart. With the use of Didanosine; the risk of developing a heart attack increases by 49%, with Abacavir; the increased risk is 90%. view more (2008-02-11)
Protecting HIV patients from Hepatitis B virus
Since the transmission of HIV and Hepatitis B virus (HBV) are so similar, individuals infected with one of these viruses are at a significantly increased risk for contracting the other. view more (2007-07-18)
Harmless virus may hold key to more effective HIV drug discovery
A simple, harmless virus might hold the key to the more effective and efficient development of HIV and anti-viral drugs, UCI chemical biologists have found. view more (2005-08-29)
Eastern Europe Facing Major Aids Epidemic (p 1035)
Authors of a review in this week's issue of THE LANCET predict that social problems in former eastern-block countries resulting in large numbers of injecting-drug users and a rise in sexually transmitted diseases will soon cause a major HIV/AIDS epidemic in eastern Europe. Fran'§oise Hamers and Angela Downs describe recent trends in the HIV... view more... (2003-03-20)
ADVERSE EFFECTS OF ANTIRETROVIRAL TREATMENT FOR HIV INFECTION (p1320)
It is well known that treatment of HIV-1 infection (that may lead to AIDS) has side effects, but there are few studies of how many people having treatment are affected by adverse reactions. In a study of 1160 people receiving antiretroviral treatment, published in The Lancet this week, Jacques Fallon and colleagues from the Swiss HIV Cohort Study... view more... (2001-10-17)
MRC Study Shows Highly Active Anti-retroviral Therapy Dramatically Cuts Deaths From AIDS
A dramatic increase in life expectancy for people infected with HIV has been achieved since the introduction of Highly Active Anti-Retroviral Therapy (HAART), say Medical Research Council (MRC) scientists today (Friday 17 October 2003). New research conducted at the MRC Clinical Trials Unit in London and published in this week's issue of The... view more... (2003-10-16)
Body's anti-HIV drug explained
Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential. view more (2008-10-13)
Study shows suppressing herpes virus may reduce infectiousness of HIV
A recent study of men co-infected with herpes simplex virus type 2 (HSV-2) and HIV revealed that drugs used to suppress HSV decrease the levels of HIV in the blood and rectal secretions, which may make patients less likely to transmit the virus. view more (2007-11-16)
When should children infected with HIV start medication
The advent of effective medications for treating HIV dramatically improved the outlook for both adults and children infected with HIV who had access to treatment, but the optimal timing for starting treatment remains controversial, particularly in children. view more (2008-03-25)
Are HIV Infection And Personality Linked?
Currently, HIV is one of the most widely spread epidemics in the world. The specificity of the mode of transmission, the well-known severity of the prognosis, and the kind of therapies used are peculiarities of this illness. Personality traits of individuals with HIV may influence conditions for the infection itself. On the other hand, it is... view more... (2004-11-18)
HIV in the nervous system - still a cause for concern?
HIV infection can be controlled with antiretroviral drugs, but it cannot be wiped out. New evidence suggests that low levels of HIV may still lead to long-term brain damage and dementia, scientists heard today (Tuesday 09 April 2002) at the spring meeting of the Society for General Microbiology at the University of Warwick. "There is concern for... view more... (2002-04-02)
|
|
| Page
1 of
94 |
1879 Results |
|
|
|
Sort By:
Page Views | Date |
|
